Liposomal NLRP3 inflammasome inhibitor suppresses in vitro and in vivo interleukin-1 production and traffics to myocardial infarction
28 August 2016 (14:00 - 18:00)
Organised by:
Abstract
About the speaker

Washington Hospital Centre, Washington, DC (United States of America)
23 More presentations in this session
Access the full session
The Event
ESC Congress 2016
28 August 2016
14:00 CET
